Die Gen-Schere Crispr galt lange als zu ungenau für den Einsatz an Embryonen. Eine neue Technik namens Base Editing zeigt nun ...
BASEL, Switzerland and CAMBRIDGE, Mass., April 27, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on translating CRISPR-Cas9 gene-editing technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results